Newsfeeds Archive - Page 59 of 167

1 minute read

Events
News

Color Star Technology To Participate In Gulf Information Technology Exhibition Oct. 10-14, Will Showcase ColorWorld Metaverse

October 10, 8:38 AM

Color Star Technology Co., Ltd. (NASDAQ:CSCW) ("Color Star" or the "Company"), an entertainment technology company with a global network that focuses on the application of technology and

CSCW

1 minute read

News

ToughBuilt Industries Announces Third Quarter Amazon Sales Of $3.91M

By Bill Haddad

October 10, 8:36 AM

ToughBuilt Industries, Inc. ("ToughBuilt") (NASDAQ:TBLT, TBLTW)))), announced today that gross sales for Q3 2022 through Amazon.com were $3.91 million. This represents a 28% rise

TBLT

1 minute read

Novavax and SK bioscience File Post Approval Change Application In South Korea For Nuvaxovid COVID-19 Vaccine As A Booster In Adults Aged 18 And Older

By Bill Haddad

October 10, 8:12 AM

https://ir.novavax.com/Switzerlands-Federal-Office-of-Public-Health-Recommends-Novavax-Nuvaxovid-TM-COVID-19-Vaccine-as-a-Booster-in-Adults-Aged-18-and-Older

NVAX

1 minute read

scPharmaceuticals Announces FDA Approval Of FUROSCIX

By Bill Haddad

October 10, 8:06 AM

BURLINGTON, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (NASDAQ:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of

SCPH

2 minute read

IRADIMED CORPORATION Withdraws 510(k) With Plans To Resubmit After Further Discussions With FDA

By Bill Haddad

October 10, 8:00 AM

IRADIMED CORPORATION (the "Company") (NASDAQ:IRMD) today announced that the Company voluntarily withdrew its 510(K) application on October 5, 2022, for its next-generation MR IV pump. Roger Susi,

IRMD

1 minute read

Swissmedic Approves Bivalent COVID-19 Booster Vaccine From Pfizer

By Bill Haddad

October 10, 7:42 AM

-Reuters

BNTX

1 minute read

Iovance Biotherapeutics Announces First Patient Dosed With PD-1 Inactivated Tumor Infiltrating Lymphocyte (TIL) Therapy

By Bill Haddad

October 10, 7:30 AM

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, announced that the first patient was dosed, and completed the safety observation

IOVA

1 minute read

News

NovaBay Pharmaceuticals’ Avenova And DERMAdoctor Products To Be Featured During October 11-12 Amazon Prime Early Access Sale

By Bill Haddad

October 10, 6:51 AM

NovaBay® Pharmaceuticals, Inc. (NYSE:NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that

NBY

1 minute read

News

Comstock’s LiNiCo Receives Permit For Lithium-Ion Battery Storage

By Bill Haddad

October 10, 6:47 AM

Comstock Inc. (NYSE:LODE) ("Comstock" and the "Company") today announced it had received unanimous approval by the Lyon County Board of County Commissioners ("BoCC") for the Conditional Use

LODE

2 minute read

Acorda Therapeutics Withdraws Proposal To Increase Authorized Shares From Special Meeting Of Stockholders

By Bill Haddad

October 10, 6:31 AM

Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced that the company has withdrawn Proposal One, a request to increase the number of authorized shares of Acorda stock, from the ballot for the Special Meeting ofAcorda Therapeutics, Inc.

ACOR